David Nutt

A tale of two Es
J Psychopharmacol 2006 20: 315-317. [PDF] [References]  

D. J. Nutt

Alcohol alternatives – a goal for psychopharmacology?
J Psychopharmacol 2006 20: 318-320. [PDF] [References]  

Wayne Hall

The regulatory challenges in engineering a safer tipple
J Psychopharmacol 2006 20: 321-322. [PDF] [References]  

Robin Room

For alcohol alternatives, the science is not the hardest part
J Psychopharmacol 2006 20: 323-324. [PDF] [References]  

Ian Ragan

Alcohol alternatives – a goal for psychopharmacology?
J Psychopharmacol 2006 20: 325-326. [PDF] [References]  

W. Miles Cox

‘Alcohol alternatives – a goal for psychopharmacology?’ by David J. Nutt
J Psychopharmacol 2006 20: 327-328. [PDF] [References]  

Marcus R. MunafÚ

Harm reduction: lessons learned from tobacco control
J Psychopharmacol 2006 20: 329-330. [PDF] [References]  

David Nutt

Reply to commentaries
J Psychopharmacol 2006 20: 331. [PDF]  

Peter M. Haddad and Serdar Dursun

Selecting antipsychotics in schizophrenia: lessons from CATIE
J Psychopharmacol 2006 20: 332-334. [PDF] [References]  

Allen E. Thornton, Jared X. Van Snellenberg, Amir A. Sepehry, and William G. Honer

The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review
J Psychopharmacol 2006 20: 335-346. [Abstract] [PDF] [References]  

Callum Livingstone and Hagen Rampes

Lithium: a review of its metabolic adverse effects
J Psychopharmacol 2006 20: 347-355. [Abstract] [PDF] [References]  

Ralf-Peter Behrendt

Dysregulation of thalamic sensory ‘transmission’ in schizophrenia: neurochemical vulnerability to hallucinations
J Psychopharmacol 2006 20: 356-372. [Abstract] [PDF] [References]  

Boris B. Quednow, Frank Jessen, Kai-Uwe Kühn, Wolfgang Maier, Irene Daum, and Michael Wagner

Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction
J Psychopharmacol 2006 20: 373-384. [Abstract] [PDF] [References]  

J. L. Reay, C. Hamilton, D. O. Kennedy, and A. B. Scholey

MDMA polydrug users show processspecific central executive impairments coupled with impaired social and emotional judgement processes
J Psychopharmacol 2006 20: 385-388. [Abstract] [PDF] [References]  

Liesbeth Reneman, T. Schilt, Maartje M. de Win, Jan Booij, Ben Schmand, Wim van den Brink, and Onno Bakker

Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users
J Psychopharmacol 2006 20: 389-399. [Abstract] [PDF] [References]  

K. Wolff, E. M. Tsapakis, A. R. Winstock, D. Hartley, D. Holt, M. L. Forsling, and K. J. Aitchison

Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population
J Psychopharmacol 2006 20: 400-410. [Abstract] [PDF] [References]  

Casey Guillot and David Greenway

Recreational ecstasy use and depression
J Psychopharmacol 2006 20: 411-416. [Abstract] [PDF] [References]  

K. Soar, J. J. D. Turner, and A. C. Parrott

Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors
J Psychopharmacol 2006 20: 417-424. [Abstract] [PDF] [References]  

H. Valerie Curran and Katy Robjant

Eating attitudes, weight concerns and beliefs about drug effects in women who use ecstasy
J Psychopharmacol 2006 20: 425-431. [Abstract] [PDF] [References]  

Gillinder Bedi and Jennifer Redman

Self-reported ecstasy use: the impact of assessment method on dosage estimates in recreational users
J Psychopharmacol 2006 20: 432-436. [Abstract] [PDF] [References]  

Jacqui Rodgers, Tom Buchanan, Carol Pearson, Andy C. Parrott, Jon Ling, Tom Heffernan, and Andrew B. Scholey

Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study
J Psychopharmacol 2006 20: 437-446. [Abstract] [PDF] [References]  

Philip N. Murphy, Michelle Wareing, and John E. Fisk

Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study
J Psychopharmacol 2006 20: 447-455. [Abstract] [PDF] [References]  

Fabrizio Schifano, John Corkery, Paolo Deluca, Adenekan Oyefeso, and A. Hamid Ghodse

Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994–2003)
J Psychopharmacol 2006 20: 456-463. [Abstract] [PDF] [References]  

Erratum
J Psychopharmacol 2006 20: 464. [PDF]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.